Zusammenfassung
Fragestellung
Rezidivfreiheit und das ästhetische Erscheinungsbild sind nach erfolgter R0-Resektion und plastischer Rekonstruktion des Gesichtes die Hauptanliegen in der chirurgischen Behandlung von Basaliomen. In dieser Studie sollten daher neben der Rezidivrate auch insbesondere die verschiedenen rekonstruktiven Techniken bewertet werden.
Patienten und Methoden
205 Patienten aus der Tumorsprechstunde, welche sich von 1998 bis 2002 einer Basaliomresektion und Gesichtshautrekonstruktion unterzogen hatten, wurden in die Studie aufgenommen und die Daten retrospektiv analysiert.
Ergebnisse
Am häufigsten waren Basaliome in der nasalen (40,5%) und orbitalen (22,9%) Region lokalisiert. Die Rezidivrate betrug 7,3% nach im Mittel 2,5 Jahren (6 Monate bis 5 Jahre). Nahlappenplastiken, Vollhauttransplantate und Dehnungsplastiken wurden am häufigsten durchgeführt, Indikationen für Spalthauttransplantate waren selten. Sensibilitätsstörungen lagen bei nur 3,6% der Dehnungsplastiken und 11,7% der Nahlappenplastiken, jedoch bei 22,7% der Vollhaut- und 38,7% der Spalthauttransplantate vor. Das ästhetische Ergebnis, evaluiert aus der klinischen Inspektion und einer Patientenskala, wurde bei 88,4% der Nahlappenplastiken, 92,6% der Dehnungsplastiken, aber bei nur 66,4% der Vollhaut- und 54% der Spalthauttransplantate als „unauffällig“ und „gut oder sehr gut“ eingestuft.
Schlussfolgerung
Nahlappen- und Dehnungsplastiken ergeben ein besseres ästhetisches und neurologisches Ergebnis nach Gesichtshautrekonstruktionen. Hauttransplantate sind Alternativverfahren bei kritischen Indikationen für Lappenplastiken.
Abstract
Background
No recurrences and optimal aesthetic outcomes after R0 resection and plastic reconstruction of the face are the goals in the surgical treatment of basal cell carcinoma. The aim of this study was to evaluate recurrence rates and to evaluate different reconstructive techniques.
Patients and methods
This study included 205 follow-up patients undergoing R0 resection of primary basal cell carcinoma and facial skin reconstruction between 1998 and 2002; data were analyzed retrospectively.
Results
The most frequent locations of basal cell carcinoma were the nasal (40.5%) and orbital (22.9%) regions. The rate of recurrence after 2.5 years (6 months–5 years) was 7.3%. Local flaps, full-thickness skin grafts, and sliding flaps were usually performed; indications for split-thickness skin grafts were rare. Disturbances of sensation were found in only 3.6% of the sliding flaps and in 11.7% of the local flaps, but 22.7% in full-thickness and 38.7% in split-thickness skin grafts. The aesthetic outcome, evaluated by clinical inspection and a patient satisfaction score, was classified as “unobtrusive” and “good or excellent” for 88.4% of local flaps, 92.6% of sliding flaps, but only for 66.4% of full-thickness and 54% of split-thickness skin grafts.
Conclusion
Local flaps and sliding flaps result in better aesthetic and neurological outcomes after reconstruction of facial skin regions. Skin grafts have their indications as an alternative procedure in cases of critical indications for flaps.
Literatur
Avril M, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E (1997) Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 76: 100–106
Bath-Hextall F, Bong J, Perkins W, Williams H (2004) Interventions for basal cell carcinoma of the skin: systematic review. BMJ 329: 705
Bieley HC, Kirsner RS, Reyes BA, Garland LD (1992) The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma. J Am Acad Dermatol 26: 754–756
Bentkover SH, Grande DM, Soto H, Kozlicak BA, Guillaume D (2002) Excision of head and neck basal cell carcinoma with rapid, sectional, frozen-section technique. Arch Facial Plast Surg 4: 114–119
Foley P (2003) A phase III randomized study comparing photodynamic therapy (PDT) using Metvix or placebo cream in nodular basal cell carcinoma (BCC). Aust J Dermatol 44: 5
Germann G, Bernstein-Sommer B, Petrovici V, Steinau HU (1992) Differential, oncologically adequate therapy of basalioma. Handchir Mikrochir Plast Chir 24: 151–158
Gilbody J, Aitken J, Green A (1994) What causes basal cell carcinoma to be the commonest cancer? Aust J Public Health 18: 218–221
Gurunluoglu R, Shafighi M, Gardetto A, Piza-Katzer H (2003) Composite skin grafts for basal cell carcinoma defects of the nose. Aesthetic Plast Surg 27: 286–292
Hall V, Leppard B, McGill J, Kesseler M, White J, Goodwin P (1986) Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 37: 33–34
Hruza GJ (1990) Mohs micrographic surgery. Otolaryngol Clin North Am 23: 845–864
Konz B (1977) Möglichkeiten zum Wundverschluss im dermatologischen Bereich. In: Konz B, Burg G (Hrsg) Dermatochirurgie in Klinik und Praxis. Springer, Berlin Heidelberg New York, S 20–40
Mackie R, Elwood J, Hawks J (1987) Links between exposure to ultraviolet radiation and skin cancer: a report of the Royal College of Physicians. JR Coll Physicians Lond 21: 91–96
Mallon E, Dawber R (1996) Cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg 22: 854–858
Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Fox T (2001) Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicentre 6-week dose-response trial. J Am Acad Dermatol 44: 807–813
Miller PK, Roenigh RK, Brodland DG, Randle HW (1992) Cutaneous micrographic surgery: Mohs procedure. Mayo Clin Proc 67: 971–980
Neumann HA (2004) Mohs‘ micrographic surgery for treatment of basal cell carcinoma of the face — results of a retrospective study and review of literature. Br J Dermatol 151: 141–147
Petit J, Avril M, Margulis A, Chassagne D, Gerbaulet A, Duvillard P (2000) Evaluation of cosmetic results of a randomised trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 105: 2544–2551
Pichardo-Velazquez P, Dominguez-Cherit J, Vega-Memije ME, Monerez-Coutiono G, Proy H (2004) Surgical optimum for nonmelanoma skin cancer. Int J Dermatol 43:148–150
Rhodes L, De Rie M, Engtrom Y (2004) Photodynamic therapy using topical methyl aminolevulinate versus surgery for nodular basal cell carcinoma: results of a multicentre randomised prospective trial. Dermatol 140:17–23
Robinson JK, Fisher SG (2000) Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol 136: 1318–1324
Robinson JK, Dahiya M (2003) Basal cell carcinoma with pulmonary and lymph node metastases causing death. Arch Dermatol 139: 643–648
Romagosa R, Saap L, Givens M, Salvarrey A, Lin He J, Hsia S (2000) A pilot study to evaluate the treatment of basal cell carcinoma with 5-flourouracil using phosphatidylcholine as a transepidermal carrier. Dermatol Surg 26: 338–340
Schrieber M, Moon T, Fox S, Davidson J (1990) The risk of developing subsequent nonmelanoma skin cancer. J Am Acad Dermatol 23: 1114–1118
Smeets NW, Kuijpers DI, Nelemans P et al (1991) Recurrence rates of treated basal cell carcinomas. Part 1: Overview. J Dermatol Surg Oncol 17: 713–718
Telfer N, Colver G, Bowers P (1999) Guidelines for the management of basal cell carcinoma. Br J Dermatol 141: 415–423
Thissen M, Nieman F, Ideler A, Berretty P, Neumann H (2000) Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 26: 759–764
Zaynoun S, Ali L, Shaib J (1985) The relationship of sun exposure and solar elastosis to basal cell carcinoma. J Am Acad Dermatol 12: 522–525
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rustemeyer, J., Thieme, V., Günther, L. et al. Erfahrungen in der chirurgischen Versorgung von Gesichtshautbasaliomen und plastischen Rekonstruktionsverfahren. Mund Kiefer GesichtsChir 9, 220–224 (2005). https://doi.org/10.1007/s10006-005-0626-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-005-0626-4